The CHOICE Faculty are involved in a wide range of funded and unfunded research projects. They have been at the forefront of creating the next generation of thinkers and leaders in the field of economic evaluations, drug safety, and health care economics. They are known internationally for their work on developing and applying methods to critically assess information needs to improve population health and prioritize research investments given limited budgets. They are collaborating with some of the leading initiatives (e.g. Institute for Clinical and Economic Review (ICER)) in the nation in assessing the value of new interventions. In addition, the CHOICE Institute has a rich history of working with decision makers, such as patients, physicians, industry and payers, providing expertise, and facilitating collaborations at the regional, national, and global level.
The future of the CHOICE faculty is bright. The faculty are poised to address many national and global challenges – from continued opportunities to inform national policy, to studying changes to the Affordable Care Act and triple aim health care, guiding WA state to achieve effective universal health insurance coverage, to determining value and guiding best practices with the increase in personalized medicines, to understanding how human behavior affects medication adherence and clinical results, to the rise of technology in healthcare, to better ensuring favorable benefit-risk of medicines and other health technologies, to growing the international platform and linking with the important work done through the Global Medicines Program.